Doctor profile · Federal record
Dr. James McCloskey, M.D.
Medical Oncology Physician (CMS: Hematology/Oncology) · Hematology (Internal Medicine) Physician · Hackensack, NJ
- NPI 1992951149
- Accepts Medicare
- MIPS 79.9 / 100 · 2023
- 18 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
92 2Nd St
Hackensack, NJ 076012191
(551) 996-3925
fax (551) 996-0574
Credentials & registration
- NPI registered
- August 2008 — 18 yrs on file
- Profile last updated
- January 26, 2022
- Year of graduation
- 2008 — 18 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- New Jersey #25MA09444800
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1992951149. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
8,800
Distinct HCPCS
10
Medicare allowed
$339,892
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units | 6,680 | 34 | $7 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 493 | 221 | $194 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 473 | 43 | $128 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 458 | 173 | $139 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 243 | 111 | $100 | |
96372 |
Injection of drug or substance under skin or into muscle | 137 | 36 | $16 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 67 | 43 | $186 | |
85097 |
Bone marrow, smear interpretation | 60 | 39 | $76 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 40 | 23 | $85 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 37 | 37 | $241 |
In context: peer comparison
Among 12 peers in this city , average services per provider: 1,060. This provider delivers 8.3× the peer median.Open Payments
Industry payments received
All-time total
$608,974
Transactions
404
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| GlaxoSmithKline, LLC. | 61 | $132,147.32 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 51 | $106,542.24 | |
| Blueprint Medicines Corporation | 104 | $92,950.75 | |
| SOBI, INC | 32 | $59,784.16 | |
| E.R. Squibb & Sons, L.L.C. | 27 | $38,518.03 | |
| JAZZ PHARMACEUTICALS INC. | 24 | $36,137.08 | |
| PharmaEssentia USA Corporation | 18 | $30,789.49 | |
| Amgen Inc. | 21 | $30,343.27 | |
| Rigel Pharmaceuticals, Inc. | 12 | $23,344.49 | |
| Incyte Corporation | 18 | $19,604.58 | |
| Stemline Therapeutics Inc. | 14 | $19,404.11 | |
| Geron Corporation | 4 | $8,016.76 | |
| ABBVIE INC. | 10 | $5,482.66 | |
| Karyopharm Therapeutics Inc. | 2 | $2,575.48 | |
| TAIHO ONCOLOGY, INC. | 6 | $2,431.92 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
691
Patients
125
Total drug cost
$5,732,515
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Jakafi (Ruxolitinib Phosphate) | Brand | 166 | 23 | $2,716,476 |
| Posaconazole | Generic | 79 | 17 | $257,445 |
| Imatinib Mesylate | Generic | 63 | 11 | $149,118 |
| Hydroxyurea | Generic | 50 | 18 | $1,325 |
| Acyclovir | Generic | 46 | 14 | $794 |
| Sprycel (Dasatinib) | Brand | 39 | 0 | $382,565 |
| Inqovi (Decitabine/Cedazuridine) | Brand | 38 | 0 | $317,933 |
| Bosulif (Bosutinib) | Brand | 37 | 0 | $469,622 |
| Venclexta (Venetoclax) | Brand | 37 | 17 | $90,731 |
| Ondansetron Hcl | Generic | 35 | 14 | $262 |
Hospital affiliations
Frequently asked questions
What is Dr. James McCloskey's medical specialty?
Dr. James McCloskey practices Medical Oncology Physician in Hackensack, NJ.
Where does Dr. James McCloskey practice?
Dr. James McCloskey practices at 92 2Nd St, Hackensack, NJ 076012191. Office phone: 5519963925.
What is Dr. James McCloskey's NPI?
Dr. James McCloskey's National Provider Identifier (NPI) is 1992951149, issued by NPPES.
Does Dr. James McCloskey accept Medicare assignment?
Yes. Dr. James McCloskey accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. James McCloskey commonly perform?
Top Medicare-reported procedures in 2023: Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS J0885); Established patient office or other outpatient visit (HCPCS 99215); Subsequent hospital care with moderate levelof medical decision making (HCPCS 99233). Source: CMS Medicare Physician & Other Practitioners file.